Healthcare

Ceryvyn Therapeutics (ASX: CYV) shares rose 20.00% to AUD 0.012 at the time of writing on 1 September 2026. Ceryvyn Therapeutics Limited (ASX: CYV) is continuing its development strategy around lymphangioleiomyomatosis, or LAM, following a change in company name and ASX code during July …

Epsilon Healthcare (ASX: EPN) shares rose 14.29% to AUD 0.024 at the time of writing on 1 September 2026. Epsilon Healthcare Limited (ASX: EPN) reported a significant operating milestone in its 30 July 2026 quarterly activities report. The company recorded quarterly receipts of AUD …

Monash IVF Group is one of Australia's leading fertility services providers, operating a network of clinics, diagnostic laboratories and ultrasound services across Australia and internationally. The company has built itsBusinessaround assisted reproductive services, including IVF treatment cycles, genetic testing and specialist obstetric ultrasound, positioning …

Echo IQ is a healthtech company developing artificial intelligence-driven diagnostic technology focused on cardiac conditions, with its flagship product, EchoSolv HF, designed to assist in the detection and assessment of heart failure using AI analysis of echocardiogram data.

Racura Oncology Ltd (ASX:RAC) has expanded its CPACS Phase 1 clinical trial into South Korea, with Ewha Womans University Seoul Hospital activated as the first Korean site able to enrol patients into the study of RC220 in combination with doxorubicin for advanced solid tumours.

Percheron Therapeutics Limited (ASX:PER) has secured firm commitments for a $2.3 million institutional placement, with the company saying the proceeds will fully fund its newly announced HMBD-002 clinical trial in acute myeloid leukaemia and support general working capital.

Higher FY26 profits, strong occupancy and a growth pipeline have put Regis on the radar of healthcare investors.